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ABSTRACT
Purpose. To determine the incidence and pattern of cer-
vical lymphatic drainage in patients with melanomas
located on the upper limb or trunk, and to evaluate our
current neck dissection protocol for those patients with a
N? neck.
Methods. Of 1192 melanoma patients who underwent
sentinel node biopsy, 631 were selected with a primary
tumor on the upper limb or trunk. All lymphoscintigrams,
SPECT/CT images and operative reports were reviewed to
determine the exact locations of sentinel nodes visualized
preoperatively and dissected during operation.
Results. Thirty-nine (6.2 %) of 631 patients with a mela-
noma on the upper limb or trunk showing cervical lymph
node drainage were identified. In 34 (87 %) of 39 patients,
sentinel nodes were excised from level IV or Vb, and in 30
of those 39 patients simultaneous from the axilla. In the
remaining five patients (13 %), sentinel nodes were col-
lected from level IIb, level III or the suboccipital region.
All collected sentinel nodes were located in the intended
dissection area for N? patients. Thirteen patients (33 %)
had a total of 22 tumor-positive sentinel nodes in either the
axilla (n = 10), level IV (n = 2), Vb (n = 9) or suboc-
cipital (n = 1).
Conclusions. Only a minority of the patients with upper
limb or trunk melanomas demonstrated lymphatic drainage
to cervical lymph node basins, with preferential drainage to
levels IV and Vb. Our current dissection protocol of levels
II–V, with or without extension to the suboccipital region,
in those patients with involved cervical sentinel nodes
seems sufficient.
Sentinel node biopsy is increasingly used to stage
patients with melanoma and has evolved into a routine
procedure for tumors originating at different sites of the
body.1 The head and neck region is known for its complex
lymphatic drainage, with melanomas draining to multiple,
bilateral and sometimes even contralateral sentinel
nodes.2–5 The high number of lymph nodes and lymphatic
vessels in a small anatomic area may contribute to this
phenomenon.6 However, despite the complex drainage
pathways, head and neck melanomas usually seem to fol-
low a somewhat predictable pattern, with preferred
drainage to the parotid and levels I–V for lesions located
anterior of the so-called watershed line and to the suboc-
cipital region and level II–V for tumors located posterior of
this line.7–9 On the basis of the primary tumor location,
O’Brien et al.10 defined the extent of several therapeutic
neck dissections.
Occasionally, primary melanomas located on the upper
limb or trunk drain to cervical lymph nodes, but studies on
that subject are scarce.11–13 Uren et al. presented 1735
patients with melanomas located on the upper limb or
upper trunk where lymphatic drainage was visualized
to a total number of 321 cervical sentinel nodes.13
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A completion neck dissection in patients with a histologi-
cally proven tumor-positive sentinel node originating from
a melanoma on the upper limb or trunk is usually advised.
The extent of therapeutic neck dissection hereby is based
on the expected drainage pathways and generally includes
levels II–V (with or without the suboccipital region).
However, in these specific cases the actual extent of the
neck dissection is still a matter of ongoing debate, because
scientific evidence for this approach is lacking. Therefore,
the aim of this study is to determine the incidence of
lymphatic drainage to cervical lymph nodes derived from
melanomas located on the upper limb or trunk in our
patient group, and to evaluate our current neck dissection
protocol of the levels II–V (with or without the suboccipital
region) in these patients with a N? neck.
PATIENTS AND METHODS
Patients
From 1192 unselected melanoma patients who under-
went sentinel node biopsy at the Netherlands Cancer
Institute or the University Medical Centre Groningen
between December 1991 and July 2010 a total of 631
patients with a primary melanoma on the upper limb or
trunk were identified. The anterior trunk melanomas were
located on the trunk from the umbilicus up to the clavicle
and on the anterior side of the shoulder, which is divided
by an imaginary line over the deltoid region. The posterior
trunk melanomas were located on the trunk from the level
of the umbilicus up to vertebra C7 and on the posterior side
of the shoulder posterior from the imaginary line. Sentinel
node biopsy was carried out if the primary tumor had a
Breslow thickness of at least 1 mm or a Clark level IV.
Imaging
On the day before operation, technetium-99m-labeled
nanocolloid (Nanocoll, Amersham Cygne, Eindhoven, The
Netherlands) was injected intradermally around the biopsy
site in a mean volume of 0.4 ml and a mean dosage of
63 MBq (2 mCi). The mean time interval between injec-
tion of the technetium-99m-labeled nanocolloid and the
actual operation is approximately 18 hours. Static images
were performed and were preceded by a dynamic study of
ten minutes. Both anterior and lateral images were rou-
tinely made. Immediate and three-hour postinjection
lymphoscintigrams were evaluated with regard to the
location, number and sequence of appearance of sentinel
nodes. At The Netherlands Cancer Institute, hybrid single-
photon emission computed tomography with CT (SPECT/
CT) was introduced in 2006 and was performed when
conventional images were difficult to interpret and for
research purposes.14 SPECT/CT was additionally per-
formed in eight patients, all treated in the Netherlands
Cancer Institute. A sentinel node was defined as a lymph
node upon which the primary tumor drains directly.15 Both
conventional lymphoscintigrams and SPECT/CT images
were used to mark the locations of the sentinel nodes on the
skin with indelible ink.
Surgical and Pathological Procedures
Lymphoscintigrams and SPECT/CT images were dis-
cussed with the surgeon before the sentinel nodes were
excised. The next day, patent blue dye (Laboratoire
Guerbet, Aulnay-Sous-Bois, France) was administered
intradermally in a mean volume of 1.0 ml, completely
surrounding the scar of the reexcision site. Ten minutes
after injection all nodal basins identified by lymphoscin-
tigraphy were explored surgically through limited
incisions. Surgical dissection was guided by a handheld
gamma ray detection probe (Neoprobe 1000 and 1500,
Johnson & Johnson Medical, Hamburg, Germany) and by
looking for blue-stained afferent lymphatic vessels that led
to blue stained sentinel lymph nodes. Once the sentinel
node had been excised, the probe was used to search the
resection bed to ensure that there were no residual sentinel
nodes. The search for additional sentinel nodes was ceased
if there was no residual activity or if this was less than ten
percent of the most active node in the same area. After
sentinel node biopsy, wide local excision was performed of
the primary melanoma site with a 1 or 2 cm margin,
depending on the Breslow thickness. All sentinel nodes
were formalin-fixed, bisected, paraffin-embedded, and cut
at a minimum of six levels at 50 to 150 lm intervals.
Pathologic evaluation included hematoxylin and eosin and
immunohistochemical staining (S-100 and MART-1). With
the exception of one patient harboring a small tumor bur-
den in the sentinel node (Starz classification I), patients
with a tumor-positive sentinel node underwent therapeutic
node dissection.16–18 Patients received a level I–III axillary
dissection for tumor-positive sentinel nodes located in the
axilla. In case a cervical positive sentinel node was col-
lected, derived from an anterior shoulder or anterior trunk
melanoma, a selective neck dissection of the levels II–V
was performed. The dissection was extended to the sub-
occipital region in case a tumor-positive sentinel node was
found in level II–V or the suboccipital region derived
from a melanoma on the posterior shoulder or posterior
trunk. Extension to the suboccipital region consists of the
‘so-called’ hockey-stick incision more posteriorly for a
posterolateral neck dissection (levels II–V including the
suboccipital region). During suboccipital dissection a thin
layer of fat and lymph nodes between the ligamentum
Melanomas on the Shoulder or Upper Trunk 3907
nuchae (medial border) and the fascia of trapezius muscle
(deep border) is removed. The supreme nuchal line and
external occipital protuberance represent the cranial border
of the dissection and an imaginary line connecting the two
mastoid processes the inferior border. The suboccipital
dissection is performed in continuity with the selective
neck dissection (II–V).19,20 Dissection of both the axilla
and neck was performed if metastases were present at each
site in the same patient. All lymph nodes collected from
regional node dissection specimens were examined in
4.0 mm sections stained with hematoxylin and eosin.
Data Analysis
To determine the precise location of sentinel nodes
visualized preoperatively and collected during operation all
lymphoscintigrams, SPECT/CT images and operative
reports were retrospectively reviewed. All patients were
monitored with a median follow-up of 54 months.
RESULTS
Patients
Thirty-nine (6.2 %) of 631 patients with a primary
melanoma located either on the upper limb or trunk were
identified with lymphatic drainage to at least one lymph
node basin in the head and neck area. All melanomas on
the upper limb were located on the anterior or posterior
shoulder. Overall patient characteristics are shown in
Table 1.
Lymphoscintigraphy and SPECT/CT
Both conventional lymphoscintigraphy and SPECT/CT
visualized a total of 112 sentinel nodes in 39 patients.
Forty-four sentinel nodes were depicted in the axilla, 67
sentinel nodes in cervical lymph node basins and one
sentinel node was seen on the lateral border of the left
scapula. In 31 (80 %) of 39 patients lymphatic drainage
from the shoulder or upper trunk was seen to level Vb, of
which 27 patients had simultaneous drainage to the axilla.
Two patients (5 %) showed lymphatic drainage to level IV
of which one also to the axilla. In the remaining six patients
(15 %), lymphatic drainage was depicted to the parotid
gland, level Va, level III, level IIa, level IIb or suboccipital.
Sentinel Node Biopsy
In 39 patients a total of 121 sentinel nodes were excised
(Table 2). Forty-four sentinel nodes were collected from
the axilla, 76 sentinel nodes from cervical lymph node
basins and one sentinel node from the lateral border of the
left scapula (Figs. 1, 2). In 32 (82 %) of 39 patients, a total
of 65 sentinel nodes were excised from level Vb. In 28 of
those 39 patients, 44 sentinel nodes were also excised from
the axilla or lateral border of the left scapula. In two
patients (5 %), five sentinel nodes were collected from
level IV, of which one also had a sentinel node in the
axilla. In the remaining five patients (13 %), two sentinel
nodes were excised from level IIb, one sentinel node from
level III and three sentinel nodes from the suboccipital
region. In two patients, these suboccipital nodes were not
visualized preoperatively, but the handheld gamma probe
detected them. All collected suboccipital sentinel nodes
were found in patients with a primary tumor located on the
upper posterior trunk or posterior shoulder. Not all
TABLE 1 Characteristics of 39 patients with a melanoma on the
upper limb or trunk
Characteristic Value







Breslow thickness (mm), median (range) 2.9 (1.0–12)
Follow-up (mo), median (range) 54 (4–162)
TABLE 2 Locations of sentinel nodes excised
Melanoma site No. of patients Location
Axilla Level IIa Level IIb Level III Level IV Level Va Level Vb Suboccipital Other
Anterior shoulder 3 4 (1) – – – – – 5 (1) –
Anterior trunk 5 3 (1) – – 1 (0) 2 (0) – 9 (0) –
Posterior shoulder 12 15 (2) – 1 (0) – – – 20 (5) 1 (1)
Posterior trunk 19 22 (6) – 1 (0) – 3 (2) – 31 (3) 2 (0) Scapula
Total 39 44 (10) – 2 (0) 1 (0) 5 (2) – 65 (9) 3 (1) 1 (0)
The total number of tumor-positive sentinel nodes found is indicated in parentheses
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preoperatively visualized sentinel nodes were collected. A
sentinel node in the parotid gland, in level Va and in level
IIa was not found during operation, because the handheld
gamma probe did not detect any radioactivity.
Pathology
In 13 (33 %) of the 39 patients, a total of 22 tumor-
positive sentinel nodes were excised. The involved sentinel
nodes were located in the axilla, level IV, level Vb or
suboccipital (Table 3). One patient did not receive any
further treatment, because only a minor tumor burden
(Starz I) was found in the involved sentinel node.16–18 In
two (17 %) of 12 patients who underwent a regional lymph
node dissection, additional tumor-positive lymph nodes
were collected. The first patient with a melanoma on the
posterior shoulder underwent a posterolateral dissection
with extension to the suboccipital region and one additional
tumor-positive lymph node was found in level Vb. The
second patient with a melanoma on the scapula underwent
both an axillary dissection and a posterolateral dissection
with extension to the suboccipital region. Two additional
tumor-positive lymph nodes were excised from the axilla
and two additional tumor-positive lymph nodes from
level Vb (Table 3). Both patients received adjuvant
radiotherapy.
Follow-up
Three of the 26 patients with a tumor-negative sentinel
node developed a recurrence, with an average follow-up of
44 (range 19–162) months. The first patient, who had a
primary tumor on the left shoulder, developed a subcuta-
neous metastasis on the left wrist and simultaneously
pulmonary metastases after 107 months and is currently
being treated with systemic therapy. The second patient
with a primary melanoma on the upper posterior trunk
developed pulmonary metastases after 32 months and died
due to these metastases 3 months later. The third patient
with a primary tumor on the right shoulder and tumor-
negative sentinel nodes removed from level IIb and Vb
developed a lymph node recurrence after 5 months in the
previously biopsied level Vb and this procedure was thus
considered falsely negative. After therapeutic neck dis-
section no other recurrences developed in the next 5 years.
Eight of 12 tumor-positive sentinel node patients who
underwent therapeutic dissection remained disease free,
with an average follow-up of 59 months (range, 17–150).
Four of 12 patients with a tumor-positive sentinel node,
who received therapeutic lymph node dissection, devel-
oped a local recurrence. In none of these latter four patients
additional tumor-positive lymph nodes were found in the
dissection specimen. The first patient developed extensive
distant metastases after 31 months and died from these
recurrences. The second patient developed brain and oro-
pharynx metastases after 24 months and is still alive
4 months later. In the third patient liver metastases were
found 9 months after neck dissection and this patient died
3 months later due to these metastases. The fourth devel-
oped patient a local recurrence in the scar of the primary
tumor excision 48 months after sentinel node biopsy,
which was reexcised and no further recurrences developed.
The patient with a tumor-positive sentinel node who
FIG. 1 Locations of eight primary melanomas on the anterior
shoulder and anterior trunk and 24 sentinel nodes draining these
primary lesions. In gray the dissection area is visualized in case a
tumor-positive sentinel node is collected
FIG. 2 Locations of 31 primary melanomas on the posterior shoulder
and posterior trunk and 97 sentinel nodes draining these primary
lesions. In gray the dissection area is visualized in case a tumor-
positive sentinel node is collected
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received no further treatment (Starz I) remained disease
free with a follow-up of 25 months. No lymph node
recurrences developed beyond the dissected neck levels in
patients who underwent a neck dissection.
DISCUSSION
This study demonstrates 39 patients with a melanoma on
the shoulder or upper trunk with drainage to at least one
cervical lymph node basin. Thirty-four (87 %) of these 39
patients had lymphatic drainage to levels IV and Vb, and
the axilla. In the remaining five patients (13 %), sentinel
nodes were collected from level IIb, level III or from the
suboccipital region. As our current dissection protocol for
patients with a tumor-positive sentinel node consist of level
II–V for melanomas located on the anterior shoulder and
anterior trunk and of level II–V with extension to the
suboccipital region for melanomas on the posterior shoul-
der and posterior trunk, 100 % of the collected cervical
sentinel nodes are covered.
The lymphatic drainage pattern from primary melano-
mas located on the shoulder or trunk to cervical lymph node
basins can’t be compared with the lymphatic drainage
pattern of head and neck melanomas. So far, no studies have
been published dealing with this specific subject. Reynolds
et al. mapped lymphatic drainage of 5239 melanoma
patients.12,21 In total, 2406 patients had melanomas located
on the trunk (above the waist or umbilicus) or upper limb.
Although the incidence of patients with cervical lymph
drainage was not reported, it could be calculated that a total
of 569 sentinel nodes were visualized in cervical lymph
node basins. A total of 508 (89 %) of 569 sentinel nodes
were visualized in level Vb (n = 330) and level Va
(n = 178), 30 sentinel nodes (5.5 %) in level IV, 15 sen-
tinel nodes (2.5 %) in level III and 11 sentinel nodes (2 %)
in level II. In contrast to our findings, two sentinel nodes
(0.5 %) were visualized in level I derived from melanomas
located just infraclavicularly. Three sentinel nodes (0.5 %)
were found in the suboccipital region, originating from
melanomas located on the upper posterior trunk and pos-
terior shoulder. In the present study 76 cervical sentinel
nodes were identified in the 39 included patients. It has to be
emphasized that the results of Reynold’s study were based
on preoperative lymphoscintigrams without confirmation
by additional dissection, as we did. The definite locations of
the sentinel node might therefore be different, as has been
shown by Jansen et al.5 In their study, a discrepancy
between sentinel node locations depicted by preoperative
imaging and collected during operation was shown in 18
(60 %) of 30 patients. The current study demonstrated this
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inconsistency in 6 (15 %) of 39 patients. For example, in
one patient a sentinel node was depicted in the parotid
preoperatively, but was collected from level IIb.
Melanoma cells detected in cervical sentinel nodes
derived from tumors on the shoulder or trunk are consid-
ered as regional metastases and therefore, outside a clinical
trial, completion neck dissection is advised. The extent of
neck dissection, as described in the methods section, is
based on the principle that only those lymph node basins
considered at risk for metastases should be removed. A
total of twelve patients with a primary melanoma located
on the shoulder or trunk underwent completion lymph node
dissection (Table 3) and in two patients (17 %) additional
tumor-positive lymph nodes were found in level Vb and the
axilla. The percentage of additional melanoma containing
lymph nodes in the head and neck region is comparable
with the percentages reported by other authors of
10–30 %.8,22–24 The safety of our current neck dissection
protocol for patients with tumor-positive cervical sentinel
nodes derived from shoulder or trunk melanoma is also
confirmed by the lack of regional recurrences developing
outside the operation field. This even could raise the
question if a more selective approach guided by the lymph
node drainage pattern is appropriate, for example, by
including only the first- and second echelon nodes in the
dissection area. Comparable to Reynolds et al., we dem-
onstrated that the vast majority of sentinel nodes are
located in level IV and Vb. Although only one tumor-
positive sentinel node was found outside these levels in the
suboccipital region, lymphatic drainage was also shown to
level II and III. On the basis of these results, and the
knowledge that anatomic boundaries of the cranial border
of level IV and Vb are hard to define, it seems adequate to
continue our current neck dissection protocol including
level II–V (with or without extension to the suboccipital
region) in the N? patients with primary melanomas located
on the shoulder or trunk.25
As in our study, Reynolds et al.12 showed lymphatic
drainage to the suboccipital region in three patients with a
melanoma located on the upper posterior trunk or posterior
shoulder. In the current study one patient had a tumor-
positive lymph node in the suboccipital area and underwent
a level II–V dissection with extension to the suboccipital
region. There were no involved nonsentinel nodes in the
suboccipital dissection specimens, but drainage to the
suboccipital region was seen in three of the 31 patients
(10 %) with a posteriorly located melanoma. This dem-
onstrates that the suboccipital region remains a potential
drainage site for metastatic cells. In our opinion, this
observation justifies treatment of the suboccipital lymph
node basin for melanomas of the posterior shoulder and
upper back in the N? neck. Nevertheless the absence of a
clear surgical boundary of this region and relatively
increased risk of flap necrosis (a thin skin flap has to be
elevated because the suboccipital nodes are mainly located
just under the skin) makes it a more delicate procedure.
The suboccipital dissection can be omitted if the risk of
morbidity is considered to exceed the potential benefit.
Strict follow-up of this specific area by ultrasound is then
recommended.
In conclusion, in our study, 39 patients are described
with a primary melanoma located on the shoulder or upper
trunk with lymphatic drainage to cervical lymph node
basins. The preferred drainage pattern was to level IV,
level Vb and the axilla, but in some cases lymphatic flow
was seen up to level II, level III or the suboccipital region.
Our current dissection protocol of the levels II–V, in case a
tumor-positive cervical sentinel node is collected in
patients with a melanoma on the anterior shoulder or
anterior upper trunk, appears to be sufficient. For patients
with an involved cervical sentinel node originating from a
primary melanoma on the posterior upper trunk or posterior
shoulder, a level II–V dissection with extension to the
suboccipital region is advised.
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